domperidone has been researched along with levodopa in 53 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 29 (54.72) | 18.7374 |
1990's | 9 (16.98) | 18.2507 |
2000's | 11 (20.75) | 29.6817 |
2010's | 4 (7.55) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Adba, MA; Aranda, B; Cramer, P | 1 |
Gancher, ST; Grandas, F; Lera, G; Nutt, JG; Obeso, JA; Rodriguez, M | 1 |
Gervason, CL; Pollak, P | 1 |
Graham, SJ; Higgins, BM; Morris, JG; Panegyres, PK; Williams, BK | 1 |
Chandler, W; Eggena, P; Stern, N; Tuck, ML | 1 |
Critchley, P; Grandas Perez, FJ; Jenner, PG; Marsden, CD; Nomoto, M; Parkes, JD; Quinn, NP; Stahl, S | 1 |
Kempster, PA; Lees, AJ; Stern, GM; Stibe, CM | 1 |
Facchinetti, F; Genazzani, AR; Golinelli, S; Oltramari, P; Petraglia, F; Santoro, V; Volpe, A | 1 |
Hashimoto, T; Koda, H; Kuriyama, K | 1 |
Agnoli, A; Brughitta, G; Ruggieri, S; Stocchi, F | 1 |
Gaio, JM; Hommel, M; Mallaret, M; Perret, J; Pollak, P | 1 |
Dugani, AM; Glavin, GB | 1 |
Bradbrook, ID; Gillies, HC; Morrison, PJ; Rogers, HJ | 1 |
Langdon, N; Malcolm, PN; Parkes, JD | 1 |
Goh, M; Hanew, K; Sasaki, A; Sato, S; Yoshinaga, K | 1 |
Cvitanović, B; Geber, J; Gjuris, V; Ivanović, D; Mise, S; Rotkvić, I; Sikirić, P; Suchanek, E; Tućan-Foretić, M | 1 |
Luquin, MR; Martínez Lage, JM; Obeso, JA | 1 |
Goh, M; Hanew, K; Sasaki, A; Sato, S; Shimizu, Y; Yoshinaga, K | 1 |
Aleksić, J; Geber, J; Gjuris, V; Ivanović, D; Marović, A; Reić, P; Sikirić, P; Suchanek, E | 1 |
McGrath, PC; Neifeld, JP | 1 |
Bános, C; Földes, J; Lakatos, P; Takó, J | 1 |
Goldberg, LI | 1 |
James, VA; Wigham, T | 1 |
Rinne, UK | 1 |
Hanew, K; Kasai, M; Murakami, O; Sasaki, A; Sato, S; Shimizu, Y; Yoshinaga, K | 1 |
Bression, D; Chanson, P; Derome, PJ; Jedynak, CP; Legentil, P; Orgiazzi, J; Peillon, F; Racadot, J; Trouillas, J | 1 |
Davies, CL; Dolan, AL; Finnerty, GT; Parkes, JD; Shindler, JS; Towlson, K | 1 |
Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, NP; Thompson, C | 1 |
Bercovici, JP; Besson, G; Maudelonde, T; Sudre, Y; Tater, D | 1 |
Lightman, SL | 1 |
Agid, Y; Illas, A; Lhermitte, F; Quinn, N | 1 |
Agid, Y; Lhermitte, F; Quinn, N | 1 |
Kojima, T; Shiozaki, Z; Shuto, K; Tanaka, M | 1 |
Andrade, LA; Azevedo-Silva, SM; Borges, V; Ferraz, HB; Rocha, MS | 1 |
Gancher, ST; Nutt, JG; Woodward, WR | 1 |
McCallum, RW; Sarosiek, I; Shifflett, J; Soykan, I; Wooten, GF | 1 |
Oertel, WH; Stiasny, K; Trenkwalder, C; Wetter, TC; Winkelmann, J | 1 |
Kuritzky, A; Melamed, E; Merims, D; Ziv, I; Zoldan, J | 1 |
Benz, S; Müller, T; Przuntek, H | 1 |
Albanese, A; Bonuccelli, U; Brefel, C; Chaudhuri, KR; Colosimo, C; Eichhorn, T; Melamed, E; Pollak, P; Van Laar, T; Zappia, M | 1 |
Grosset, D; Grosset, K; Macphee, G; Needleman, F | 1 |
Belforte, JE; Benarroch, EE; Cersósimo, MG; Micheli, FE; Pazo, JH; Tumilasci, OR | 1 |
Moritoyo, H; Moritoyo, T; Nagai, M; Nakatsuka, A; Nisikawa, N; Nomoto, M; Yabe, H | 1 |
Muhlack, S; Müller, T | 1 |
Burguera, JA; Martínez-Castrillo, JC | 1 |
Choi, YJ; Kim, JM; Kim, KJ; Kim, N; Lee, DH; Lee, JY; Lee, YJ; Shin, CM | 1 |
3 review(s) available for domperidone and levodopa
Article | Year |
---|---|
[Use of apomorphine in the treatment of Parkinson's disease].
Topics: Apomorphine; Domperidone; Drug Combinations; Humans; Infusions, Intravenous; Injections, Subcutaneous; Levodopa; Parkinson Disease | 1991 |
Dopamine receptors and hypertension. Physiologic and pharmacologic implications.
Topics: Animals; Benzazepines; Blood Pressure; Bromocriptine; Domperidone; Dopamine; Ergolines; Fenoldopam; Humans; Hypertension; Levodopa; Quinpirole; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Vasoconstriction; Vasodilation | 1984 |
[Proposed alternative to standard apomorphine challenge test].
Topics: Antidotes; Antiparkinson Agents; Apomorphine; Carbidopa; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Injections, Subcutaneous; Levodopa; Motor Activity; Parkinson Disease; Severity of Illness Index; Time Factors | 2012 |
10 trial(s) available for domperidone and levodopa
Article | Year |
---|---|
Sublingual apomorphine solution in Parkinson's disease.
Topics: Administration, Oral; Administration, Sublingual; Apomorphine; Domperidone; Drug Therapy, Combination; Female; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Parkinson Disease; Single-Blind Method | 1991 |
Blood pressure effects of apomorphine and domperidone in parkinsonism.
Topics: Adult; Aged; Aged, 80 and over; Apomorphine; Blood Pressure; Clinical Trials as Topic; Domperidone; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation; Shy-Drager Syndrome | 1987 |
Bromocriptine and domperidone in the treatment of Parkinson disease.
Topics: Benzimidazoles; Bromocriptine; Domperidone; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Piperidines; Vomiting | 1981 |
Apomorphine tolerance in Parkinson's disease: lack of a dose effect.
Topics: Antiparkinson Agents; Apomorphine; Domperidone; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Infusions, Intravenous; Levodopa; Parkinson Disease; Psychomotor Performance | 1996 |
Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Domperidone; Dopamine Antagonists; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Emptying; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Selegiline; Severity of Illness Index | 1997 |
Treatment of restless leg syndrome with pergolide--an open clinical trial.
Topics: Aged; Antiparkinson Agents; Domperidone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Pergolide; Restless Legs Syndrome; Treatment Outcome | 1998 |
[Apomorphine for treatment of "off-periods" in Parkinson's disease].
Topics: Aged; Antiparkinson Agents; Apomorphine; Domperidone; Female; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Vomiting | 1999 |
Quantitative study of salivary secretion in Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Amylases; Analysis of Variance; Antiparkinson Agents; Case-Control Studies; Domperidone; Dopamine Antagonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Rest; Salivation; Secretory Rate | 2006 |
Impact of endurance exercise on levodopa-associated cortisol release and force increase in patients with Parkinson's disease.
Topics: Adult; Aged; Antiemetics; Antiparkinson Agents; Benserazide; Domperidone; Drug Administration Schedule; Exercise Test; Exercise Therapy; Exercise Tolerance; Hand Strength; Humans; Hydrocortisone; Levodopa; Middle Aged; Muscle Strength; Parkinson Disease; Physical Endurance; Physical Fitness; Stress, Physiological; Treatment Outcome | 2008 |
DA-9701 on gastric motility in patients with Parkinson's disease: A randomized controlled trial.
Topics: Aged; Antiemetics; Antiparkinson Agents; Domperidone; Double-Blind Method; Female; Gastric Emptying; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Plant Preparations; Stomach; Treatment Outcome | 2018 |
40 other study(ies) available for domperidone and levodopa
Article | Year |
---|---|
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Effect of apomorphine on the bladder of parkinsonian patients].
Topics: Aged; Aged, 80 and over; Apomorphine; Domperidone; Drug Therapy, Combination; Female; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Parkinson Disease; Urinary Bladder Diseases; Urodynamics | 1992 |
Differences in the motor response to apomorphine between untreated and fluctuating patients with Parkinson's disease.
Topics: Adult; Aged; Apomorphine; Carbidopa; Domperidone; Humans; Levodopa; Middle Aged; Parkinson Disease; Psychomotor Performance | 1992 |
Effects of central and peripheral dopamine antagonism on aldosterone secretion: evidence for adrenal mechanism.
Topics: Adrenal Cortex; Aldosterone; Animals; Captopril; Cerebral Ventricles; Dexamethasone; Domperidone; Dopamine Antagonists; Injections, Intraventricular; Levodopa; Male; Metoclopramide; Rats; Rats, Inbred Strains; Renin | 1989 |
(+)-4-Propyl-9-hydroxynaphthoxazine in Parkinson's disease.
Topics: Animals; Callithrix; Carbidopa; Domperidone; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Oxazines; Parkinson Disease; Time Factors | 1986 |
Subcutaneous apomorphine in parkinsonian on-off oscillations.
Topics: Adult; Aged; Apomorphine; Domperidone; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infusion Pumps; Injections, Subcutaneous; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1988 |
Evidences for a dopamine-regulated peripheral source of circulating beta-endorphin.
Topics: Acetylcholine; Adult; beta-Endorphin; beta-Lipotropin; Blood-Brain Barrier; Bromocriptine; Dexamethasone; Domperidone; Dopamine; Humans; Levodopa; Male; Metoclopramide; Nomifensine; Reference Values | 1988 |
[Emetic and catalepsy-inducing actions of buflomedil].
Topics: Administration, Oral; Animals; Bromocriptine; Catalepsy; Dogs; Domperidone; Dose-Response Relationship, Drug; Levodopa; Male; Mice; Pyrrolidines; Vomiting | 1988 |
Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation.
Topics: Administration, Oral; Adult; Aged; Carbidopa; Domperidone; Ergolines; Female; Humans; Infusions, Intravenous; Levodopa; Lisuride; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1986 |
Effects of dopamine agonists and antagonists on gastric acid secretion and stress responses in rats.
Topics: Animals; Corticosterone; Domperidone; Dopamine; Dopamine Antagonists; Gastric Juice; Immobilization; Levodopa; Methylphenidate; Metoclopramide; Rats; Stomach Ulcer; Stress, Psychological | 1987 |
The effects of domperidone on the absorption of levodopa in normal subjects.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Domperidone; Female; Half-Life; Humans; Intestinal Absorption; Kinetics; Levodopa | 1986 |
Comparison of levodopa with carbidopa, and levodopa with domperidone in Parkinson's disease.
Topics: Adult; Aged; Benserazide; Carbidopa; Domperidone; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1986 |
Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
Topics: Acromegaly; Adult; Blood-Brain Barrier; Bromocriptine; Domperidone; Dopamine; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Prolactin; Sulpiride | 1987 |
Dopamine antagonists induce gastric lesions in rats.
Topics: Animals; Bromocriptine; Domperidone; Dopamine Antagonists; Female; Haloperidol; Levodopa; Male; Metoclopramide; Rats; Rats, Inbred Strains; Stomach Ulcer | 1986 |
Intravenous lisuride corrects oscillations of motor performance in Parkinson's disease.
Topics: Adult; Aged; Domperidone; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Injections, Intravenous; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1986 |
The dopaminergic regulation of plasma growth hormone secretion in normal subjects.
Topics: Adult; Domperidone; Dopamine; Growth Hormone; Humans; Levodopa; Male; Median Eminence; Pituitary Gland; Prolactin | 1986 |
The role of dopamine in the formation of gastric ulcers in rats.
Topics: Animals; Apomorphine; Bromocriptine; Domperidone; Dopamine; Female; Haloperidol; Levodopa; Male; Rats; Rats, Inbred Strains; Stomach Ulcer; Sulpiride | 1985 |
Inhibition of human neuroblastoma by dopamine antagonists.
Topics: Animals; Cell Division; Cell Line; Domperidone; Dopamine; Dopamine Antagonists; Female; Humans; Levodopa; Mice; Mice, Nude; Neuroblastoma; Pimozide; Receptors, Dopamine; Spiperone | 1985 |
Effect of domperidone on serum TSH and growth hormone in thyroid patients.
Topics: Adult; Domperidone; Female; Growth Hormone; Humans; Levodopa; Middle Aged; Stimulation, Chemical; Sulpiride; Thyroid Diseases; Thyrotropin | 1985 |
Evidence for dopaminergic and serotonergic regulation of prolactin cell activity in the trout Salmo gairdneri.
Topics: 5-Hydroxytryptophan; Animals; Domperidone; Dopamine; Fenclonine; Levodopa; Pituitary Gland; Prolactin; Salmonidae; Serotonin; Somatostatin; Thyrotropin-Releasing Hormone; Trout; Tryptophan | 1984 |
Dopamine agonists in the treatment of Parkinson's disease.
Topics: Blood Pressure; Bromocriptine; Disability Evaluation; Domperidone; Dopamine; Ergolines; Follow-Up Studies; Humans; Levodopa; Parkinson Disease; Pleural Effusion; Receptors, Neurotransmitter; Time Factors | 1983 |
Plasma growth hormone responses to sulpiride in patients with acromegaly.
Topics: Acromegaly; Adult; Domperidone; Dopamine; Female; Growth Hormone; Humans; Hypophysectomy; Levodopa; Male; Middle Aged; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1984 |
Paradoxical response of thyrotropin to L-dopa and presence of dopaminergic receptors in a thyrotropin-secreting pituitary adenoma.
Topics: Adenoma; Adult; Domperidone; Female; Humans; In Vitro Techniques; Levodopa; Pituitary Neoplasms; Receptors, Dopamine; Thyrotropin; Thyrotropin-Releasing Hormone | 1984 |
Domperidone and levodopa in Parkinson's disease.
Topics: Aged; Blood Pressure; Domperidone; Drug Interactions; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1984 |
Pergolide in the treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Domperidone; Ergolines; Humans; Levodopa; Mental Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Pergolide | 1984 |
Similar response to dopaminergic or anti-dopaminergic drugs in acromegaly.
Topics: Acromegaly; Domperidone; Female; Growth Hormone; Humans; Levodopa; Male; Receptors, Dopamine | 1984 |
Studies on the responses of plasma renin activity and aldosterone and cortisol levels to dopaminergic and opiate stimuli in man.
Topics: Adult; Aldosterone; Carbidopa; Domperidone; Dopamine; Female; Humans; Hydrocortisone; Levodopa; Male; Naloxone; Posture; Renin | 1981 |
[Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)].
Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benzimidazoles; Bromocriptine; Domperidone; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperidines | 1981 |
Antagonism of KW-5338 (domperidone) against emesis and depression of intestinal motility induced by L-DOPA.
Topics: Animals; Antiemetics; Dogs; Domperidone; Female; Gastrointestinal Motility; Levodopa; Male; Mice; Tremorine; Trihexyphenidyl | 1980 |
[Apomorphine: an alternative in the control of motor fluctuations in Parkinson's disease].
Topics: Antiparkinson Agents; Apomorphine; Domperidone; Dopamine Antagonists; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1995 |
Choice reaction time after levodopa challenge in parkinsonian patients.
Topics: Adult; Aged; Domperidone; Drug Interactions; Female; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Psychomotor Performance; Reaction Time; Treatment Outcome | 2000 |
Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease.
Topics: Apomorphine; Corpus Striatum; Decision Making; Domperidone; Dopamine Agonists; Dopamine Antagonists; Drug Administration Schedule; Guidelines as Topic; Humans; Levodopa; Parkinson Disease; Substantia Nigra; Time Factors | 2001 |
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles | 2004 |
[Inter- and intraindividual pharmacokinetic variations in the treatment of Parkinson's disease].
Topics: Antiparkinson Agents; Area Under Curve; Domperidone; Dopamine Antagonists; Drug Interactions; Humans; Individuality; Levodopa; Parkinson Disease | 2005 |